Immucell (ICCC) Annual Balance Sheets

Annual · GAAP · USD millions
Access ICCC quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Immucell's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent3.81
Cash & Short-term Investments3.00
Accounts receivable3.42
Other Receivables, Net, Current0.00
Inventories9.27
Derivatives, Collateral, Regulatory, Deferred0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.45
Total Current Assets16.94
Equipment/Property/Plant Net21.07
Goodwill net0.10
Intangible Assets0.00
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent4.42
Total Assets42.53
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.28
Accounts Payable and Accrued Liabilities LI0.00
Long-term Debt, Current Maturities LO1.61
Other Liabilities, Current0.09
Deferred Tax Liabilities, Net, Current LI0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities3.98
Long-term debt7.49
Total Long-term Debt7.49
Other liabilities, Noncurrent4.01
Total Liabilities15.48
Stockholders' Equity
Common Stock Value0.91
Treasury Stock Value0.00
Additional Paid In Capital Common Stock41.48
Retained Earnings / Accumulated Deficit-15.20
Other Equity-0.13
Common Stockholder's Equity27.06
Total Stockholder's Equity27.06
Liabilities & Stockholder's Equity42.53
4 historic quarters locked

Sign in to unlock the full Immucell balance sheet history.

About Immucell Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-010339

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.